Sarepta Therapeutics Inc (SRPT)
110.51
-0.35
(-0.32%)
USD |
NASDAQ |
Nov 21, 16:00
111.10
+0.59
(+0.53%)
After-Hours: 20:00
Sarepta Therapeutics Market Cap: 10.56B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 10.59B |
| November 19, 2024 | 10.18B |
| November 18, 2024 | 9.998B |
| November 15, 2024 | 9.986B |
| November 14, 2024 | 10.42B |
| November 13, 2024 | 10.74B |
| November 12, 2024 | 10.92B |
| November 11, 2024 | 11.26B |
| November 08, 2024 | 11.62B |
| November 07, 2024 | 11.50B |
| November 06, 2024 | 12.22B |
| November 05, 2024 | 11.94B |
| November 04, 2024 | 11.76B |
| November 01, 2024 | 11.78B |
| October 31, 2024 | 12.03B |
| October 30, 2024 | 12.20B |
| October 29, 2024 | 12.43B |
| October 28, 2024 | 12.44B |
| October 25, 2024 | 12.52B |
| October 24, 2024 | 12.61B |
| October 23, 2024 | 12.40B |
| October 22, 2024 | 12.26B |
| October 21, 2024 | 12.16B |
| October 18, 2024 | 12.14B |
| October 17, 2024 | 11.87B |
| Date | Value |
|---|---|
| October 16, 2024 | 12.02B |
| October 15, 2024 | 11.82B |
| October 14, 2024 | 11.88B |
| October 11, 2024 | 11.89B |
| October 10, 2024 | 11.69B |
| October 09, 2024 | 11.27B |
| October 08, 2024 | 11.43B |
| October 07, 2024 | 11.25B |
| October 04, 2024 | 11.50B |
| October 03, 2024 | 11.34B |
| October 02, 2024 | 11.70B |
| October 01, 2024 | 11.68B |
| September 30, 2024 | 11.93B |
| September 27, 2024 | 11.88B |
| September 26, 2024 | 11.91B |
| September 25, 2024 | 11.88B |
| September 24, 2024 | 11.97B |
| September 23, 2024 | 11.90B |
| September 20, 2024 | 12.13B |
| September 19, 2024 | 12.12B |
| September 18, 2024 | 11.92B |
| September 17, 2024 | 11.99B |
| September 16, 2024 | 11.86B |
| September 13, 2024 | 11.89B |
| September 12, 2024 | 11.95B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
5.266B
Minimum
Jul 19 2021
15.49B
Maximum
Jun 24 2024
9.619B
Average
9.910B
Median
Market Cap Benchmarks
| Catalyst Pharmaceuticals Inc | 2.520B |
| Madrigal Pharmaceuticals Inc | 7.179B |
| Vertex Pharmaceuticals Inc | 115.99B |
| Viking Therapeutics Inc | 5.757B |
| Regenxbio Inc | 456.31M |
Market Cap Related Metrics
| PE Ratio | 71.76 |
| PS Ratio | 6.779 |
| Price to Book Value | 8.645 |
| Price | 110.51 |
| Earnings Yield | 1.39% |
| Operating PE Ratio | 137.23 |
| Normalized PE Ratio | 67.74 |